Morgan Stanley’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.4M | Buy |
|
|||||
|
2025
Q1 | $77M | Sell |
|
|||||
|
2024
Q4 | $114M | Sell |
|
|||||
|
2024
Q3 | $90.5M | Sell |
|
|||||
|
2024
Q2 | $83.5M | Buy |
|
|||||
|
2024
Q1 | $45.7M | Sell |
|
|||||
|
2023
Q4 | $62.5M | Buy |
|
|||||
|
2023
Q3 | $17.9M | Buy |
|
|||||
|
2023
Q2 | $15.5M | Buy |
|
|||||
|
2023
Q1 | $12.9M | Sell |
|
|||||
|
2022
Q4 | $9.35M | Buy |
|
|||||
|
2022
Q3 | $15K | Sell |
|
|||||
|
2022
Q2 | $31K | Buy |
|
|||||
|
2022
Q1 | $40K | Sell |
|
|||||
|
2021
Q4 | $152K | Buy |
|
|||||
|
2021
Q3 | $58K | Buy |
|